Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilli  W.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli,
Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN method  Kleinkauf N. , Rodloff A.C.   Clinical Microbiology.
In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria  Matthew W. Ruble, Deborah H. Gilbert, Stephen.
M.A.C. Broeren, Y. Maas, E. Retera, N.L.A. Arents 
Approach to diagnosis of infective endocarditis
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America 
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes  G. Kronvall, G. Kahlmeter, E.
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Herpes zoster in non-hospitalized children
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes  G. Kronvall, G. Kahlmeter, E.
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program  M.
J. Cairo, R. Hachem, G. Rangaraj, B. Granwehr, I. Raad 
Revision of linezolid disk diffusion quality control guidelines for testing Staphylococcus aureus ATCC 25923: an independent seven-laboratory trial  D.J.
Potential risk factors for infection with Candida spp
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
C.G. Giske, C. Borén, B. Wretlind, G. Kronvall 
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
A. Bousquet, J. -V. Malfuson, N. Sanmartin, J. Konopacki, C. MacNab, B
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Training for the infectious diseases speciality in Norway
Laboratory diagnosis and biosafety issues of biological warfare agents
C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R
G. Kronvall  Clinical Microbiology and Infection 
S. Bengtsson, C. Bjelkenbrant, G. Kahlmeter 
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions  M. Sjölund, S. Bengtsson, J. Bonnedahl,
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
C. S. Higgins, S. M. Murtough, E. Williamson, S. J. Hiom, D. J
Effect of antioxidants on the immune response of Helicobacter pylori
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
Laboratory diagnosis of Clostridium difficile disease
Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe  Anna King, Julie Downes, Carl-Erik Nord, Ian.
Recent developments in staphylococcal scalded skin syndrome
Pathogenesis of catheter-related infections: lessons for new designs
Single- and multistep selection study of the antipneumococcal activity of BMS compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin 
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Community-acquired pneumonia: epidemiologic and clinical consideration
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Definition of the Clinical Antibacterial Spectrum of Activity
Clinical infection services—the Leiden experience
Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit  S. Nseir, C. Blazejewski, R. Lubret,
Clinical Microbiology and Infection
Evaluation of the CLSI cefoxitin 30-µg disk-diffusion method for detecting methicillin resistance in staphylococci  L.-X. Zhu, Z.-W. Zhang, C. Wang, H.-W.
M. Kaase, S. Lenga, S. Friedrich, F. Szabados, T. Sakinc, B. Kleine, S
Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species  G. Kronvall, E. Holst  Clinical Microbiology.
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory 
Modification of prescribers’ behavior: the Icelandic approach
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species†   C.B. Moore,
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
Typing of Clostridium difficile
Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3- ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant.
B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P
The future of diagnostic bacteriology
Presentation transcript:

Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilli  W. Howard, D.J. Biedenbach, R.N. Jones  Clinical Microbiology and Infection  Volume 8, Issue 6, Pages 340-344 (June 2002) DOI: 10.1046/j.1469-0691.2002.00399.x Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Scattergrams comparing the BMS284756 MIC with the zone of inhibition around a 5-μg disk when testing: (a) Pseudomonas aeruginosa (129 strains); (b) Acinetobacter spp., 43 strains; and (c) Stenotrophomonas/Burkholderia spp., 97 strains. Vertical broken lines indicate preliminary zone diameter breakpoint criteria correlating with the proposed ≤4 mg/L MIC indicating susceptibility [7]. Clinical Microbiology and Infection 2002 8, 340-344DOI: (10.1046/j.1469-0691.2002.00399.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.